Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Volume 39, Issue 5, Pages 406-411
Publisher
Wiley
Online
2012-01-03
DOI
10.1111/j.1440-1681.2012.05670.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-inflammatory effect of atorvastatin in patients with aortic sclerosis or mild aortic stenosis independent of hypercholesterolemia
- (2014) Pawel P. Dimitrow et al. Pharmacological Reports
- Functional SYNTAX Score for Risk Assessment in Multivessel Coronary Artery Disease
- (2011) Chang-Wook Nam et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- An important role for VCAM-1, but not for ICAM-1 in restenosis following coronary stent implantation
- (2010) Serdar Bayata et al. Anadolu Kardiyoloji Dergisi-The Anatolian Journal of Cardiology
- Short-Term Treatment with High-Dose Atorvastatin Reduces LDL Cholesterol but Shows no Anti-Inflammatory Effects in Normolipidemic Subjects with Normal CRP Levels
- (2010) John S. Millar et al. CTS-Clinical and Translational Science
- Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism
- (2010) Qian Zhang et al. Evidence-based Complementary and Alternative Medicine
- Berberine suppresses proinflammatory responses through AMPK activation in macrophages
- (2009) Hyun Woo Jeong et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Inflammatory Protein Levels and Depression Screening After Coronary Stenting Predict Major Adverse Coronary Events
- (2009) Lorraine Frazier et al. Biological Research for Nursing
- Meta-analysis of the role of high-dose statins administered prior to percutaneous coronary intervention in reducing major adverse cardiac events in patients with coronary artery disease
- (2009) Pan-Pan Hao et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Berberine-induced decline in circulating CD31+/CD42− microparticles is associated with improvement of endothelial function in humans
- (2009) Jie-mei Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages
- (2009) Zhouqing Huang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression
- (2009) Hao Zhang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study
- (2009) F. Affuso et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Impact of lipid lowering therapy on liver function
- (2009) György Paragh et al. ORVOSI HETILAP
- Efficacy of berberine in patients with type 2 diabetes mellitus
- (2008) Jun Yin et al. METABOLISM-CLINICAL AND EXPERIMENTAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More